DZ2769A1 - Composés tricycliques substitués. - Google Patents

Composés tricycliques substitués.

Info

Publication number
DZ2769A1
DZ2769A1 DZ990069A DZ990069A DZ2769A1 DZ 2769 A1 DZ2769 A1 DZ 2769A1 DZ 990069 A DZ990069 A DZ 990069A DZ 990069 A DZ990069 A DZ 990069A DZ 2769 A1 DZ2769 A1 DZ 2769A1
Authority
DZ
Algeria
Prior art keywords
substituted tricyclics
tricyclics
substituted
Prior art date
Application number
DZ990069A
Other languages
English (en)
French (fr)
Inventor
Anderson Benjamin Alan
Bach Nicholas James
Bastian Jolie Anne
Ham Nancy Kay
Harper Richard Waltz
Hite Gary Alan
Kinnick Michael Dean
Lin Ho-Shen
Richard James Loncharich
John Mcneil Mcgill
Edward David Mihelich
John Michael Morin Jr
Michael Leroy Philips
Michael Enrico Richett
Daniel Jon Sall
Jason Scott Sawyer
Richard Walter Schevitz
Robert Theodore Vasileif
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ2769A1 publication Critical patent/DZ2769A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ990069A 1998-04-17 1999-04-14 Composés tricycliques substitués. DZ2769A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6232898A 1998-04-17 1998-04-17

Publications (1)

Publication Number Publication Date
DZ2769A1 true DZ2769A1 (fr) 2003-12-01

Family

ID=22041763

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990069A DZ2769A1 (fr) 1998-04-17 1999-04-14 Composés tricycliques substitués.

Country Status (30)

Country Link
EP (2) EP0950657B1 (de)
JP (2) JPH11322713A (de)
KR (2) KR19990083232A (de)
CN (1) CN1149193C (de)
AR (2) AR018186A1 (de)
AT (2) ATE271037T1 (de)
AU (2) AU753436B2 (de)
BR (2) BR9902365A (de)
CA (2) CA2269246C (de)
CO (2) CO5011054A1 (de)
CZ (2) CZ136999A3 (de)
DE (2) DE69917833T2 (de)
DK (1) DK0950657T3 (de)
DZ (1) DZ2769A1 (de)
EA (2) EA002816B1 (de)
ES (2) ES2226286T3 (de)
HU (2) HUP9901221A3 (de)
ID (2) ID23287A (de)
IL (2) IL129483A0 (de)
NO (2) NO314400B1 (de)
NZ (3) NZ335251A (de)
PE (2) PE20000432A1 (de)
PL (2) PL332566A1 (de)
PT (1) PT950657E (de)
SG (2) SG81977A1 (de)
SI (1) SI0950657T1 (de)
TR (2) TR199900853A3 (de)
TW (1) TWI238160B (de)
YU (2) YU18999A (de)
ZA (2) ZA992771B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009978A1 (en) * 1997-08-28 1999-03-04 Eli Lilly And Company Method for treatment of non-rheumatoid athritis
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.
AU1940800A (en) * 1998-12-21 2000-07-12 Eli Lilly And Company Combination therapy for the treatment of sepsis
ATE350367T1 (de) * 1999-07-19 2007-01-15 Lilly Co Eli Spla2 inhibitoren
US6706752B1 (en) 1999-07-19 2004-03-16 Eli Lilly And Company sPLA2 inhibitors
US20040102442A1 (en) * 2000-06-29 2004-05-27 Kohji Hanasaki Remedies for alzheimer's disease
US20040077651A1 (en) * 2000-06-29 2004-04-22 Kohji Hanasaki Remedies for cancer
WO2002000256A1 (en) * 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedies for cirrhosis
CA2413582A1 (en) * 2000-07-14 2002-01-24 Eli Lilly And Company Use of a spla2 inhibitor for the treatment of sepsis
AU2002239263A1 (en) * 2000-12-18 2002-07-01 Eli Lilly And Company Tetracyclic carbazole derivates and their use as spla2 inhibitors
US6933313B2 (en) 2001-03-28 2005-08-23 Eli Lilly And Company Substituted carbazoles as inhibitors of sPLA2
AUPS282602A0 (en) 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
DE10249055A1 (de) 2002-10-22 2004-05-06 Bayer Cropscience Ag 2-Phenyl-2-substituierte-1,3-diketone
JO3598B1 (ar) 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
EP1988098A1 (de) * 2007-04-27 2008-11-05 AEterna Zentaris GmbH Neue Tetrahydrocarbazolderivate als Liganden von G-Protein-gekoppelten Rezeptoren
EP2256105B1 (de) 2008-03-26 2013-12-04 Daiichi Sankyo Company, Limited Neuartiges tetrahydroisochinolin-derivat
TW201000107A (en) 2008-04-09 2010-01-01 Infinity Pharmaceuticals Inc Inhibitors of fatty acid amide hydrolase
US8580795B2 (en) 2009-01-22 2013-11-12 Orchid Chemicals & Pharmaceuticals Limited Heterocyclic compounds as phosphodiesterase inhibitors
JP2012523424A (ja) 2009-04-07 2012-10-04 インフイニトイ プハルマセウトイカルス インコーポレイテッド 脂肪酸アミドヒドロラーゼの阻害薬
EP2417115A4 (de) 2009-04-07 2012-10-31 Infinity Pharmaceuticals Inc Fettsäureamidhydrolase-hemmer
CA2788587C (en) 2010-02-03 2020-03-10 Infinity Pharmaceuticals, Inc. Fatty acid amide hydrolase inhibitors
AR088377A1 (es) 2011-10-20 2014-05-28 Siena Biotech Spa Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta
CN102816107B (zh) * 2012-08-20 2015-06-03 东南大学 咔唑衍生物及其制备方法与用途
MX2015006871A (es) 2012-11-30 2015-09-16 Ge Healthcare Ltd Proceso de cristalizacion de derivados de indoles triciclicos.
CA2889642A1 (en) * 2012-11-30 2014-06-05 Ge Healthcare Limited Zinc halide mediated cyclization process leading to tricyclic indoles
WO2016116527A1 (de) * 2015-01-20 2016-07-28 Cynora Gmbh Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen
CN108707104A (zh) * 2018-08-07 2018-10-26 北京恒信卓元科技有限公司 2-氯-1h-咔唑-1,4(9h)-二酮的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579534A (en) * 1969-05-09 1971-05-18 American Cyanamid Co Tetrahydrocarbazolecarboxylates
US3939177A (en) * 1972-11-22 1976-02-17 Sterling Drug Inc. 4-Aminomethyl-9-benzyl-1,2,3,4-tetrahydrocarbazoles
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
US5420289A (en) * 1989-10-27 1995-05-30 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
US5472978A (en) * 1991-07-05 1995-12-05 Merck Sharp & Dohme Ltd. Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
EP0749962B1 (de) * 1995-06-23 2000-11-02 Eli Lilly And Company 6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole
CA2240395A1 (en) * 1995-12-13 1997-06-19 David Kent Herron Naphthyl acetamides as spla2 inhibitors
IL129481A0 (en) * 1996-10-30 2000-02-29 Lilly Co Eli Substituted tricyclics
WO1999016453A1 (en) * 1997-09-26 1999-04-08 Eli Lilly And Company Method for the treatment of cystic fibrosis
JP2001522884A (ja) * 1997-11-14 2001-11-20 イーライ・リリー・アンド・カンパニー アルツハイマー病の処置方法
DZ2769A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Composés tricycliques substitués.

Also Published As

Publication number Publication date
TWI238160B (en) 2005-08-21
IL129485A0 (en) 2000-02-29
AU2381799A (en) 1999-10-28
NO991821D0 (no) 1999-04-16
EA002816B1 (ru) 2002-10-31
SG81976A1 (en) 2001-07-24
HU9901221A (hu) 2000-04-28
KR19990083233A (ko) 1999-11-25
CN1253948A (zh) 2000-05-24
ID23287A (id) 2000-04-05
HUP9901221A3 (en) 2001-11-28
EP0952149B1 (de) 2004-06-09
TR199900853A2 (xx) 1999-11-22
DK0950657T3 (da) 2004-11-22
PT950657E (pt) 2004-11-30
CA2269262A1 (en) 1999-10-17
IL129483A0 (en) 2000-02-29
YU18999A (sh) 2002-08-12
NO312240B1 (no) 2002-04-15
HU9901220A (hu) 2000-04-28
EP0952149A2 (de) 1999-10-27
PE20000432A1 (es) 2000-05-23
CO5011054A1 (es) 2001-02-28
HUP9901220A3 (en) 2001-11-28
CZ136999A3 (cs) 1999-11-17
EP0950657A2 (de) 1999-10-20
ZA992772B (en) 2002-07-16
NO991822L (no) 1999-10-18
AU753436B2 (en) 2002-10-17
CA2269246C (en) 2009-08-25
KR100586761B1 (ko) 2006-06-08
AU2381999A (en) 1999-10-28
BR9901279A (pt) 2000-05-02
BR9902365A (pt) 2001-04-24
DE69917833T2 (de) 2005-07-14
EA199900303A2 (ru) 1999-10-28
CN1149193C (zh) 2004-05-12
EA002347B1 (ru) 2002-04-25
ATE271037T1 (de) 2004-07-15
CA2269246A1 (en) 1999-10-17
NZ507564A (en) 2002-10-25
PL332566A1 (en) 1999-10-25
ES2226286T3 (es) 2005-03-16
JPH11322713A (ja) 1999-11-24
DE69917833D1 (de) 2004-07-15
HU9901221D0 (en) 1999-06-28
EP0950657A3 (de) 2001-08-16
EP0950657B1 (de) 2004-07-14
YU19199A (sh) 2002-08-12
DE69918590D1 (de) 2004-08-19
EA199900301A2 (ru) 1999-10-28
TR199900853A3 (tr) 1999-11-22
NO991821L (no) 1999-10-18
ES2222663T3 (es) 2005-02-01
KR19990083232A (ko) 1999-11-25
SG81977A1 (en) 2001-07-24
EA199900301A3 (ru) 2000-04-24
PL332565A1 (en) 1999-10-25
TR199900843A2 (xx) 2000-02-21
DE69918590T2 (de) 2005-07-21
NO991822D0 (no) 1999-04-16
EA199900303A3 (ru) 2000-04-24
NZ335251A (en) 2000-11-24
EP0952149A3 (de) 2001-08-16
ATE268756T1 (de) 2004-06-15
NO314400B1 (no) 2003-03-17
ZA992771B (en) 2002-04-18
CZ137099A3 (cs) 1999-11-17
CO5031247A1 (es) 2001-04-27
AR018593A1 (es) 2001-11-28
AU753547B2 (en) 2002-10-24
SI0950657T1 (en) 2005-02-28
PE20000476A1 (es) 2000-06-02
HU9901220D0 (en) 1999-06-28
JP2000026416A (ja) 2000-01-25
ID23761A (id) 2000-05-11
JP4435330B2 (ja) 2010-03-17
NZ335253A (en) 2000-11-24
AR018186A1 (es) 2001-10-31

Similar Documents

Publication Publication Date Title
DZ2769A1 (fr) Composés tricycliques substitués.
LU93311I2 (fr) Mancozèbe, valifenalate
CU23049A3 (es) Dihidropirimidinas.
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
IT1312540B1 (it) Composto.
DE69829169D1 (de) Vielfach-optischen-Weg Lichtschalter.
ZA992773B (en) Substituted tricyclics.
ID26909A (id) Turunan-turunan 1,3,4-oksadiazolon
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
DE69906149D1 (de) 4,5-azolo-oxindole
NL1011999A1 (nl) Trisresorcinyltriazinen.
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
BR9908946B1 (pt) forração.
ATE231848T1 (de) Substituierte 2-benzoyl-cyclohexan-1,3-dione
ITTO980674A0 (it) Elicottero.
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
DZ2644A1 (fr) Triazolo-Ä3,4-aÜ-pyridazine substituées en 1,2,4.
ES1039413Y (es) Nueva ficha-deportista.
ES1039687Y (es) Linterna.
ES1041377Y (es) Lampara.
ES1041087Y (es) Lampara.
ES1042604Y (es) Conjunto de iluminacion.
ES1040343Y (es) Carrito portafregona.
ES1042117Y (es) Mesa-sombrilla.
ES1040589Y (es) Expositor-dispensador.